Clinical trial
The Efficacy/Safety Profile Of Pulsed Shortwave Therapy in Cervical Osteoarthritis: A Comparison Study Against Etoricoxib
NCT03542955 is registered in ClinicalTrials.gov with BioElectronics Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy/Safety Profile Of Pulsed Shortwave Therapy in Cervical Osteoarthritis: A Comparison Study Against Etoricoxib
- Lead sponsor
- BioElectronics Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 1, 2018
- Completion date
- July 30, 2019
- Enrollment
- 180 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cervical osteoarthritis